Carregant...

RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE

Special systems were developed for response assessment of immunooncology drugs. The role and benefits of particular system in assessing the efficacy of different immunotherapy methods are not clear yet. The objective of this study is to compare the responses on ipilimab (IPI) or dendritic cell vacci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: A. V. Novik, E. V. Yaremenko, E. M. Anokhina, T. L. Nehaeva, A. I. Semenova, D. Kh. Latipova, S. A. Protsenko, I. A. Baldueva
Format: Artigo
Idioma:Russo
Publicat: Tomsk National Research Medical Center of the Russian Academy of Sciences 2019-09-01
Col·lecció:Sibirskij Onkologičeskij Žurnal
Matèries:
Accés en línia:https://www.siboncoj.ru/jour/article/view/1136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!